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Response to the Letter to the Editor:  
“The prognostic value of white blood cell  
count-to-mean platelet volume ratio  
in patients with acute coronary syndrome”
We would like to thank Murat Yuksel et al. [1] 
for their comments on our article [2]. They have 
asked if we consider that the elevated levels of 
mean platelet volume (MPV) and total white blood 
cell (WBC) count predict cardiovascular events in 
acute coronary syndrome (ACS) patients; therefore 
the WBC/MPV ratio (WMR) values may not be 
considered a good prognostication marker due to 
dividing WBC by MPV. Although they offered some 
comments regarding the association of inflamma-
tory markers with ACS, they should focus more on 
MPV and total WBC count in non-ST elevation ACS 
(NSTE-ACS) instead of platelet and lymphocyte 
counts. Given their notions and those mentioned 
in our article, we propose some points in this letter.
The prognostic role of MPV has been dem-
onstrated among patients with myocardial infarc-
tion (MI) [3], however, findings in terms of MPV 
have not been consistent among NSTE-ACS or 
NSTEMI. Tekbas et al. [4] have shown that el-
evated MPV increased the risk of mortality in ST 
elevation MI (STEMI) during hospitalization, but 
not in NSTEMI group. Taglieri et al. [5] have also 
demonstrated that, among NSTE-ACS patients, el-
evated MPV group was at higher risk for combined 
cardiovascular death and MI, while the association 
with each of the endpoints alone has decreased. 
Furthermore, in another prospective study, MPV 
was not associated with 6-month adverse events in 
NSTE-ACS patients [6]. One reason for this issue 
can be explained by findings of Rinder et al. [7], who 
have found that the interaction between platelets 
and leukocytes at culprit lesion of atherosclerotic 
plaques, leading to inflammatory pathways and 
subsequent atherothrombosis, is a dynamic pro-
cess attributable to platelet activation status and 
leukocyte adhesion ability. Thus, it is likely that 
in the progression of NSTE-ACS, both activated 
and inactivated platelets are involved, which may 
be suggestive of the fact why increased MPV is 
not associated with adverse events in NSTE-ACS. 
Beside the MPV values, the majority of studies 
have shown that higher total WBC count has been 
a prognostic marker for patients at greater risk 
for developing cardiovascular adverse events at 
follow-up duration in ACS patients [8], MI alone 
[9], or NSTE-ACS [10].
Taking into account these findings and the 
prognostic role of WMR as a novel inflammation-
based marker reflecting both MPV and WBC count 
effects in ACS, it seems more likely to consider 
that the WMR may not be useful in STEMI pa-
tients due to a vast amount of studies showing 
association between elevated MPV and STEMI 
prognosis. On the other hand, the prognostic abil-
ity of WMR in predicting patients at greater risk 
for worse outcomes in NSTE-ACS may be of great 
importance because of lack of association between 
elevated MPV and outcomes of such patients. 
Further large-scaled prospective study may be 
useful in elucidating the importance of WMR in 
the risk stratification and treatment modalities of 
NSTE-ACS patients.
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